Literature DB >> 20186856

Dementia incidence continues to increase with age in the oldest old: the 90+ study.

María M Corrada1, Ron Brookmeyer, Annlia Paganini-Hill, Daniel Berlau, Claudia H Kawas.   

Abstract

OBJECTIVE: The oldest old are the fastest growing segment of the US population, and accurate estimates of dementia incidence in this group are crucial for healthcare planning. Although dementia incidence doubles every 5 years from ages 65 to 90 years, it is unknown if this exponential increase continues past age 90 years. Here, we estimate age- and sex-specific incidence rates of all-cause dementia in people aged 90 years and older, including estimates for centenarians.
METHODS: Participants are from The 90+ Study, a population-based longitudinal study of aging and dementia. Three hundred thirty nondemented participants aged 90 years and older at baseline were followed between January 2003 and December 2007. Age- and sex-specific incidence rates of all-cause dementia were estimated by person-years analysis.
RESULTS: The overall incidence rate of all-cause dementia was 18.2% (95% confidence interval [CI], 15.3-21.5) per year and was similar for men and women (risk ratio, 0.94; 95% CI, 0.65-1.37). Rates increased exponentially with age from 12.7% per year in the 90-94-year age group, to 21.2% per year in the 95-99-year age group, to 40.7% per year in the 100+-year age group. The doubling time based on a Poisson regression was 5.5 years.
INTERPRETATION: Incidence of all-cause dementia is very high in people aged 90 years and older and continues to increase exponentially with age in both men and women. Projections of the number of people with dementia should incorporate this continuing increase of dementia incidence after age 90 years. Our results foretell the growing public health burden of dementia in an increasingly aging population.

Entities:  

Mesh:

Year:  2010        PMID: 20186856      PMCID: PMC3385995          DOI: 10.1002/ana.21915

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

1.  APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.

Authors:  K Juva; A Verkkoniemi; P Viramo; T Polvikoski; K Kainulainen; K Kontula; R Sulkava
Journal:  Neurology       Date:  2000-01-25       Impact factor: 9.910

2.  Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: the 90+ study.

Authors:  Kristin Kahle-Wrobleski; Maria M Corrada; Bixia Li; Claudia H Kawas
Journal:  J Am Geriatr Soc       Date:  2007-02       Impact factor: 5.562

3.  Survival among patients with dementia from a large multi-ethnic population.

Authors:  Stephen C Waring; Rachelle S Doody; Valory N Pavlik; Paul J Massman; Wenyaw Chan
Journal:  Alzheimer Dis Assoc Disord       Date:  2005 Oct-Dec       Impact factor: 2.703

4.  APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+.

Authors:  R Sulkava; K Kainulainen; A Verkkoniemi; L Niinistö; E Sobel; Z Davanipour; T Polvikoski; M Haltia; K Kontula
Journal:  Neurobiol Aging       Date:  1996 May-Jun       Impact factor: 4.673

5.  Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group.

Authors:  L Letenneur; L J Launer; K Andersen; M E Dewey; A Ott; J R Copeland; J F Dartigues; P Kragh-Sorensen; M Baldereschi; C Brayne; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Am J Epidemiol       Date:  2000-06-01       Impact factor: 4.897

6.  Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study.

Authors:  C B Hall; J Verghese; M Sliwinski; Z Chen; M Katz; C Derby; R B Lipton
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

7.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

8.  Prevalence of dementia after age 90: results from the 90+ study.

Authors:  M M Corrada; R Brookmeyer; D Berlau; A Paganini-Hill; C H Kawas
Journal:  Neurology       Date:  2008-07-02       Impact factor: 9.910

9.  The incidence of dementia: a meta-analysis.

Authors:  A F Jorm; D Jolley
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

10.  Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Authors:  L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman
Journal:  Neurology       Date:  1999-01-01       Impact factor: 9.910

View more
  163 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments.

Authors:  Carrie B Peltz; María M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

4.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

Review 5.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

Review 6.  Diagnosing dementia in the oldest-old.

Authors:  Carrie Brumback-Peltz; Archana B Balasubramanian; María M Corrada; Claudia H Kawas
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

Review 7.  Homeostatic disinhibition in the aging brain and Alzheimer's disease.

Authors:  Marc Gleichmann; Vivian W Chow; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Poor physical performance and dementia in the oldest old: the 90+ study.

Authors:  Szofia S Bullain; Maria M Corrada; Barbara Agee Shah; Farah H Mozaffar; Martina Panzenboeck; Claudia H Kawas
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

9.  Incidence rates of dementia, Alzheimer disease, and vascular dementia in the Japanese American population in Seattle, WA: the Kame Project.

Authors:  Amy R Borenstein; Yougui Wu; James D Bowen; Wayne C McCormick; Jay Uomoto; Susan M McCurry; Gerard D Schellenberg; Eric B Larson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

10.  Cognitive Aging and Dementia: A Life Span Perspective.

Authors:  Elliot M Tucker-Drob
Journal:  Annu Rev Dev Psychol       Date:  2019-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.